- Home
- TCMD vs ZTR Comparison
TCMD vs ZTR Comparison
Compare TCMD & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCMD | ZTR |
|---|---|---|
| Founded | 1995 | 1988 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.1M | 357.2M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | TCMD | ZTR |
|---|---|---|
| Price | $29.21 | $6.30 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.25 | N/A |
| AVG Volume (30 Days) | ★ 332.5K | 219.4K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.09% |
| EPS Growth | ★ 18.66 | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $311,513,000.00 | N/A |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $8.83 | N/A |
| P/E Ratio | $38.69 | ★ N/A |
| Revenue Growth | ★ 9.28 | N/A |
| 52 Week Low | $8.61 | $4.50 |
| 52 Week High | $30.24 | $6.60 |
Technical Indicators
Market Signals| Indicator | TCMD | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 66.16 | 43.59 |
| Support Level | $29.02 | $6.26 |
| Resistance Level | $29.92 | $6.34 |
| Average True Range (ATR) | 0.92 | 0.05 |
| MACD | -0.22 | 0.00 |
| Stochastic Oscillator | 60.90 | 59.09 |
Price Performance
Historical ComparisonAbout TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.